Select Medical Holdings Corporation (SEM)

Jul 1, 2026 - SEM was delisted (reason: acquired by consortium)

16.51

-0.02 (-0.12%)

Inactive · Last trade price on Jun 30, 2026

Select Medical Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,048	1,839	2,432	3,013	3,153	3,944
Market Cap Growth	5.77%	-24.38%	-19.30%	-4.44%	-20.05%	5.80%
Enterprise Value	5,014	4,888	7,194	8,154	8,274	8,582
Last Close Price	16.51	14.73	18.38	12.15	12.60	14.62

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.38	12.87	11.49	12.48	19.77	10.14
Forward PE	12.69	12.27	13.19	10.93	12.92	10.87
PS Ratio	0.37	0.34	0.47	0.62	0.68	0.64
PB Ratio	1.17	0.90	1.22	1.91	2.27	2.89
P/FCF Ratio	13.47	15.68	8.22	8.54	33.38	17.87
P/OCF Ratio	5.28	5.31	4.70	5.18	11.07	9.83
PEG Ratio	0.92	1.97	0.93	0.48	0.86	0.57

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.91	0.90	1.39	1.69	1.80	1.38
EV/EBITDA Ratio	10.78	10.26	17.50	20.24	33.30	11.11
EV/EBIT Ratio	15.58	14.54	26.81	30.51	71.14	15.05
EV/FCF Ratio	32.99	41.69	24.33	23.11	87.59	38.89

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.42	1.41	1.35	2.88	3.71	3.49
Debt / EBITDA Ratio	3.97	3.75	3.94	6.84	10.42	4.30
Debt / FCF Ratio	19.69	24.47	9.15	12.82	54.60	21.58
Net Debt / Equity Ratio	1.41	1.40	1.32	2.80	3.58	3.44
Net Debt / EBITDA Ratio	6.38	5.97	6.43	10.95	20.06	6.07
Net Debt / FCF Ratio	19.52	24.24	8.94	12.51	52.77	21.24
Asset Turnover	0.94	0.95	0.78	0.63	0.61	0.83
Quick Ratio	1.00	0.93	0.92	0.68	0.98	0.78
Current Ratio	1.15	1.04	1.04	1.01	1.10	0.90
Return on Equity (ROE)	9.81%	10.64%	7.28%	7.45%	1.35%	33.15%
Return on Assets (ROA)	3.43%	3.67%	2.52%	2.18%	0.97%	4.75%
Return on Invested Capital (ROIC)	5.09%	5.56%	3.75%	3.42%	0.98%	7.79%
Return on Capital Employed (ROCE)	6.30%	6.90%	5.80%	4.10%	1.80%	9.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	6.36%	7.95%	8.80%	8.08%	5.04%	10.20%
FCF Yield	7.42%	6.38%	12.16%	11.71%	3.00%	5.60%
Dividend Yield	1.51%	1.70%	2.38%	4.12%	3.97%	3.42%
Payout Ratio	23.30%	21.50%	30.19%	26.25%	40.62%	12.58%
Buyback Yield / Dilution	3.15%	1.58%	-1.23%	1.22%	4.32%	-0.36%
Total Shareholder Return	4.66%	3.28%	1.16%	5.34%	8.29%	3.06%

SEC Filings: 10-K · 10-Q